The Comparative study of 0.75percent Ropivacaine and 0.5percent Levobupivacaine in Peripheral Nerve Stimulator guided Supraclavicular and Axillary Brachial plexus block for upper limb Surgeries

Comparison of 0.75 percent Ropivacaine and 0.5percent Levobupivacaine in Peripheral Nerve Stimulator guided Supraclavicular and Axillary Brachial plexus block for upper limb Surgeries - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110842

Enrollment

Registered

2026-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V020- Pedestrian injured in collision with two- or three-wheeled motor vehicle in nontraffic accident

Interventions

Intervention1: The Supraclavicular And Axillary Brachial plexus block using Peripheral Nerve Stimulator: The study population is divided into 2 groups 35 each Group R will recieve 0.75 percent Ropivac

Eligibility

Inclusion criteria

Inclusion criteria: CRITERIA 1. Patients giving consent for the procedure 2 Patient posted for upper limb surgery (upper extremity below shoulder) 3. Patients with age group between 18 & 60 years 4. Patients with ASA I & II

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA 1. Patient not giving consent for the procedure 2. Patient having local infection at the site of the injection 3. Patient with coagulation or bleeding disorder 4. Patients with pre-existing respiratory (pneumothorax, severe respiratory disorder) cardiac, diabetes mellitus, neurological disorders, hepatic or renal disease 5. Patient with known case of bradycardia, hypotension 6. Patient with hypersensitivity to LA (ropivacaine, levobupivacaine, lignocaine)

Design outcomes

Primary

Measure	Time frame
To compare onset, duration of sensory, motor and analgesic outcome of Ropivacaine and LevobupivacaineTimepoint: To compare onset, duration of sensory, motor and analgesic outcome of Ropivacaine and Levobupivacaine	—

Secondary

Measure	Time frame
To compare intraoperative & post operative hemodynamic parameter (HR, SBP, DBP, MAP, RR, SPO2) between two groups To compare the VAS score & any additional intra op analgesic requirement between the groups To compare the incidence of intra operative & post operative complications between the groups. Surgeon satisfaction score Likert scaleTimepoint: To compare intraoperative & post operative hemodynamic parameter	—

Measure

Time frame

To compare intraoperative & post operative hemodynamic parameter (HR, SBP, DBP, MAP, RR, SPO2) between two groups To compare the VAS score & any additional intra op analgesic requirement between the groups To compare the incidence of intra operative & post operative complications between the groups. Surgeon satisfaction score Likert scaleTimepoint: To compare intraoperative & post operative hemodynamic parameter

—

Countries

India

Contacts

Public ContactDr Ajay Kumar Sinha

Government Medical College,Haldwani

sinhauk1961@gmail.com9897672301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026